comparemela.com
Home
Live Updates
Lutetium Lu 177 Dotatate Reduced Risk of Death By 72% Compar
Lutetium Lu 177 Dotatate Reduced Risk of Death By 72% Compar
Lutetium Lu 177 Dotatate Reduced Risk of Death By 72% Compared to Comparator in Patients With Advanced GEP-NETs
Radioligands may be able to deliver radiation to advanced tumor cells anywhere in the body.
Related Keywords
Canada ,
United States ,
Toronto ,
Ontario ,
Simron Singh ,
Jeff Legos ,
University Of Toronto ,
Novartis ,
Odette Cancer Centre In Ontario ,
Susan Leslie Clinic ,
Neuroendocrine Tumours ,
Odette Cancer Centre ,